We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
+$103K
Cap. Flow
-$916M
Cap. Flow %
-4.16%
Top 10 Hldgs %
10.55%
Holding
2,302
New
567
Increased
501
Reduced
537
Closed
688

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$168M
2
CNP icon
CenterPoint Energy
CNP
+$151M
3
NFLX icon
Netflix
NFLX
+$132M
4
EFX icon
Equifax
EFX
+$132M
5
SRE icon
Sempra
SRE
+$122M

Sector Composition

Rank Sector Weight
1 Financials 14.98%
2 Technology 10.51%
3 Consumer Discretionary 10.34%
4 Industrials 8.24%
5 Healthcare 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGR icon
1401
Sturm, Ruger & Co
RGR
$592M
$468K ﹤0.01%
6,784
-80,816
-92% -$4.89M
VEEV icon
1402
Veeva Systems
VEEV
$38.3B
$465K ﹤0.01%
+4,269
New +$387K
ENR icon
1403
Energizer
ENR
$1.5B
$464K ﹤0.01%
7,911
-1,388
-15% -$87.3K
WTTR icon
1404
Select Water Solutions
WTTR
$2.68B
$463K ﹤0.01%
39,109
+23,422
+149% +$322K
SC
1405
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$463K ﹤0.01%
23,102
-168,518
-88% -$3.46M
SWN
1406
DELISTED
Southwestern Energy Company
SWN
$460K ﹤0.01%
90,068
-3,967,332
-98% -$21M
SIEN
1407
DELISTED
Sientra, Inc.
SIEN
$455K ﹤0.01%
+1,907
New +$419K
SRNE
1408
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$454K ﹤0.01%
+103,252
New +$572K
BPMC
1409
DELISTED
Blueprint Medicines
BPMC
$452K ﹤0.01%
+5,785
New +$402K
CCS icon
1410
Century Communities
CCS
$1.96B
$449K ﹤0.01%
17,088
+10,294
+152% +$308K
GMED icon
1411
Globus Medical
GMED
$11.6B
$445K ﹤0.01%
7,832
-99,235
-93% -$5.22M
LPSN icon
1412
LivePerson
LPSN
$31.7M
$444K ﹤0.01%
+1,142
New +$421K
BID
1413
DELISTED
Sotheby's
BID
$443K ﹤0.01%
9,007
+4,151
+85% +$210K
RY icon
1414
Royal Bank of Canada
RY
$294B
$440K ﹤0.01%
+5,486
New +$430K
ESPR
1415
DELISTED
Esperion Therapeutics
ESPR
$439K ﹤0.01%
9,894
-31,330
-76% -$1.44M
AWR icon
1416
American States Water
AWR
$3.44B
$438K ﹤0.01%
+7,158
New +$430K
AVTA
1417
DELISTED
Avantax, Inc. Common Stock
AVTA
$438K ﹤0.01%
+10,874
New +$396K
BTI icon
1418
British American Tobacco
BTI
$123B
$431K ﹤0.01%
+9,233
New +$469K
ACOR
1419
DELISTED
Acorda Therapeutics
ACOR
$431K ﹤0.01%
+183
New +$566K
XLRN
1420
DELISTED
Acceleron Pharma
XLRN
$428K ﹤0.01%
7,476
-715
-9% -$35.1K
WNC icon
1421
Wabash National
WNC
$508M
$426K ﹤0.01%
+23,383
New +$442K
CATM
1422
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$424K ﹤0.01%
13,404
+2,286
+21% +$70.3K
EGOV
1423
DELISTED
NIC Inc
EGOV
$420K ﹤0.01%
+28,359
New +$459K
TXNM
1424
TXNM Energy Inc
TXNM
$5.91B
$419K ﹤0.01%
+10,621
New +$416K
MO icon
1425
Altria Group
MO
$111B
$417K ﹤0.01%
6,919
-89,533
-93% -$5.32M

Similar funds

Balyasny Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Balyasny Asset Management held 2,302 positions worth $22B, up 0% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $916M in Q3 2018, closing 688 positions and reducing 537 holdings. Its most notable exit was DuPont de Nemours, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Equifax worth $132M.

  • Balyasny Asset Management's largest Q3 2018 buy was Equifax: 1,013,016 shares worth $132M.
  • Balyasny Asset Management added most to Walt Disney in Q3 2018, an estimated $168M increase.
  • Balyasny Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $335M.
  • Balyasny Asset Management fully exited DuPont de Nemours in Q3 2018, selling an estimated $144M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q3 2018.
  • Balyasny Asset Management opened 567 new positions and closed 688 in Q3 2018.
  • Balyasny Asset Management's portfolio value rose 0% quarter-over-quarter to $22B.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.